Bilateral TKA is proven to be safe in a select group of patients. Patients with symptomatic bilateral knee arthritis who are not candidates for simultaneous bilateral TKA are subjected to staged surgery. The main objective of this study is to determine the safe window when second TKA can be performed in patients requiring bilateral TKA Retrospective study includes bilateral TKA cases performed in a single institution between 2000–2018. A cohort of simultaneous bilateral TKA (n=2728) was compared to cohort of staged bilateral TKA (n=1660). Outcomes in terms of complications, reoperation, 30 days readmission and cumulative revision rates were compared between the two groups using both non-adjusted and adjusted models.Introduction
Methods
Recovery after total knee arthroplasty (TKA) may take longer than patients expect. Furthermore, there are a subset of patients who still experience pain and dissatisfaction despite normal physical examination, radiographs, and laboratory analysis. Corticosteroid injection (CSI) is commonly used nonsurgical treatment for painful knee arthritis. However, the efficacy of CSI in patients with a painful TKA remains unknown. A retrospective charge review was performed to identify a cohort of patients who had a primary TKA performed between 2015 and 2016 and later received a CSI. All TKAs and CSIs were performed by a fellowship-trained arthroplasty surgeon. Patients receiving a CSI underwent a clinical exam, laboratory analysis to rule out infection, and radiographic evaluation prior to injection. Patient variables were recorded and a survey assessed the efficacy of the injection. The survey response rate was 63.6%.Introduction
Methods
The differential diagnosis of pain after total knee arthroplasty (TKA) should always include periprosthetic infection (PPI). The current diagnostic tools vary in sensitivity, specificity, and predictive value. Currently there is no test with an absolute accuracy for diagnosis of PPI. Furthermore, cost effectiveness of investigations has become an important issue in recent years as increased expenses can place an unnecessary heavy burden on the medical system. We retrospectively evaluated 296 patients who underwent revision TKA at our institution during 2000–2005 and had preoperative erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) performed. The criteria used for diagnosing infection were a positive intraoperative culture on solid media, presence of an abscess or sinus tract that communicated with the joint, positive preoperative aspiration culture, and/or elevated fluid cell count and neutrophil differential of the aspirated fluid. The sensitivity, specificity, and predictive values of ESR and CRP were determined. Combinations were performed in parallel that necessitate both tests to be negative to rule out infection. The cost of each serological test was compared to that of other commonly used screening modalities. One hundred and sixteen patients (39%) were classified as infected and 180 patients (61%) were considered non-infected. The sensitivity, specificity, positive predictive value, and negative predictive value for the ESR were: 91%, 72%, 68%, and 93%. The sensitivity, specificity, positive predictive value, and negative predictive value for the CRP were: 94%, 74%, 70%, and 95%. The sensitivity and negative predictive value for the combined studies were 96% and 95%, respectively. However, five infected patients (4%) had a normal ESR and CRP. An organism was cultured on solid media in 4 of the 5 cases. ESR and CRP were the least costly of all the preoperative tests including radionuclide imaging and joint fluid analysis. ESR and CRP are important preoperative tests in diagnosis of PPI and their ability to clench the diagnosis in the majority of cases should not be underestimated. When combined, these simple serological tests have improved sensitivity and negative predictive value to rule out infection.